The EXPLORER-HCM trial, originally published in The Lancet, looked at the role of mavacamten as a potential treatment for hypertrophic cardiomyopathy. Wanting to help patients and other non-specialists understand this study, the authors have developed a plain language summary of the publication.
Written by Cynthia Burstein Waldman (a patient author) and Anjali Owens, this new article called ‘A plain language summary of the EXPLORER-HCM study: mavacamten for obstructive hypertrophic cardiomyopathy’ has been published in Future Cardiology.
Read the article in full here.
The original article, entitled ‘Mavacamten for Treatment of Symptomatic Obstructive Hypertrophic Cardiomyopathy (EXPLORER-HCM): A Randomised, Double-blind, Placebo-controlled, Phase 3 Trial’, published in The Lancet, can be found here.